Ayala Pharmaceuticals Inc (AYLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 36,982 | 42,025 | 16,725 | 26,097 | N/A |
| Marketable Securities | 122 | 90 | 83 | 167 | N/A |
| Receivables | N/A | 681 | 469 | N/A | N/A |
| TOTAL | $39,740 | $44,240 | $17,694 | $26,852 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 1,120 | 1,283 | 1,421 | 241 | N/A |
| Other Non-Current Assets | 267 | 305 | 939 | 32 | 0 |
| TOTAL | $1,387 | $1,588 | $2,360 | $273 | $N/A |
| Total Assets | $41,127 | $45,828 | $20,054 | $27,125 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,472 | 6,877 | 5,302 | 2,774 | 0 |
| TOTAL | $6,472 | $6,877 | $5,302 | $2,774 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 497 | 553 | 299 | 0 | 0 |
| TOTAL | $497 | $553 | $299 | $N/A | $N/A |
| Total Liabilities | $6,969 | $7,430 | $5,601 | $2,774 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,080 | 13,170 | N/A | N/A | N/A |
| Common Shares | 139 | 128 | 51 | 50 | N/A |
| Retained earnings | -111,141 | -70,887 | -40,741 | -22,949 | N/A |
| TOTAL | $34,158 | $38,398 | $14,453 | $24,351 | $N/A |
| Total Liabilities And Equity | $41,127 | $45,828 | $20,054 | $27,125 | $0 |